APA (7th ed.) Citation

Hao, Y., Xu, M., Zeng, X., Wang, Y., Wang, W., Lin, G., . . . Song, Z. (2024). Poor efficacy of immune checkpoint inhibitor treatment in advanced thymic carcinoma patients with liver metastases. Therapeutic Advances in Medical Oncology, 16, . https://doi.org/10.1177/17588359241253127

Chicago Style (17th ed.) Citation

Hao, Yue, et al. "Poor Efficacy of Immune Checkpoint Inhibitor Treatment in Advanced Thymic Carcinoma Patients with Liver Metastases." Therapeutic Advances in Medical Oncology 16 (2024). https://doi.org/10.1177/17588359241253127.

MLA (9th ed.) Citation

Hao, Yue, et al. "Poor Efficacy of Immune Checkpoint Inhibitor Treatment in Advanced Thymic Carcinoma Patients with Liver Metastases." Therapeutic Advances in Medical Oncology, vol. 16, 2024, https://doi.org/10.1177/17588359241253127.